← Back
Data updated: Mar 10, 2026
SYNTHON BV
Pharmaceuticals
SYNTHON BV is a generic drug manufacturer with 3 FDA-approved products.
2010
Since
3
Drugs
-
Trials
33
Approved (2yr)
Key Drugs
No active drugs
Recent Activity
LEVOCETIRIZINE DIHYDROCHLORIDE 2026-01-07
Labeling
TAMSULOSIN HYDROCHLORIDE 2025-11-18
Manufacturing (CMC)
TAMSULOSIN HYDROCHLORIDE 2025-09-30
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
LEVOCETIRIZINE DIHYDROCHLORIDE 2025-07-11
Labeling
SEC Filings
Pro
Loading...
Therapeutic Focus
Score weights: Approved drugs ×3, Phase 3 ×2, Phase 2 ×1, Phase 1 ×0.5
No indication data
Pipeline Strength Pro
Loading...
Discontinued (0)
Company Info
- First Approval
- 2010-04-27
- Latest
- 2025-07-11
- Applications
- 3